2025

Wed, January 15, 20259:00-10:00 AM
S-214
Natalie Torok, MD
Stanford University
The extracellular matrix in liver cancer
Wed, February 19, 20259:00-10:00 AM
S-214
Elizabeth K. Speliotes, MD, PhD, MPH
University of Michigan
Precision Therapies for Obesity and MASLD Guided by Human Genetics
Mon, March 10, 20254:00-5:00 PM
HSW-302
Anna Lok, MD
University of Michigan
Hepatitis B - Then and Now
Wed, May 21, 20259:00-10:00 AM
S-214
Sylvester Black, MD, PhD
Ohio State University
The Healing Window: Leveraging Machine Perfusion as a Therapeutic Platform to Rescue Marginal Donor Organs
Wed, September 10, 20259:00-10:00 AM
S-214
Nataliya Razumilava, MD
University of Michigan
Understanding mechanisms regulating the bile duct responses to injury: bench to bedside
Wed, October 22, 202510:00-11:00 AM
HSW-303
Jeffrey Glenn, MD, PhD
Stanford University 
Targeting both sides of the virus-host landscape - for hepatitis and beyond 
Wed, December 17, 20259:00-10:00 AM
CS-0101
 

Mazen Noureddin, MD
Houston Methodist Hospital 
Antifibrotic Efficacy of Efruxifermin in MASH: Results from Phase 2 Clinical Trials 

Kitty Yale, BS
Akero Therapeutics 
Clinical Validation of Antifibrotic Effect of FGF21 Analogs in MASH